Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, SARS-CoV-2 test
Clinical narrative: Mild headache; body ache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Mild headache) and MYALGIA (body ache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 052E21A and 050F21A) for COVID-19 vaccination.     The patient's past medical history included Flu (Got sick for 2 weeks,Doctors said it was the flu.) in November 2021. Previously administered products included for Flu vaccination: Flu Vaccination (Happened several times, so cannot take the flu vaccine because got sick.), Flu Vaccination (Cannot take flu vaccine because gets a reaction. Arm swelled up and oozy, arm swelled up.), INFLUENZA (Cannot take flu vaccine because gets a reaction. Arm swelled up and oozy and arm swelled up.). Past adverse reactions to the above products included Peripheral swelling with INFLUENZA; Sickness with Flu Vaccination; and Skin oozing with Flu Vaccination. Concurrent medical conditions included Allergy, Food allergy (Quite a few to foods and medications. Off top of head: Foods - chicken,), Milk allergy (Quite a few to foods and medications. Off top of head: Foods -Dairy), Food allergy (Quite a few to foods and medications. Off top of head: Foods -Wheat), Gluten sensitivity, Allergy to antibiotic (Allergies: Biaxin), Allergy to antibiotic (Allergies: Cipro), Fibromyalgia worsened (Fibromyalgia has gotten worse, but everything else is fine), Blood pressure high, Depression, Neuropathy, Bursitis, Vitamin D deficiency, High cholesterol, Drug allergy (Medications: Celebrex), Drug allergy (Medications:Hydrochlorothiazide) and Drug allergy (Medications: Statins.). Concomitant products included FLUTICASONE for Allergy, DILTIAZEM for Blood pressure high, MELOXICAM for Bursitis, FLUOXETINE and LEVOMEFOLIC ACID (L-METHYLFOLATE) for Depression, HYDROCODONE for Fibromyalgia, EVOLOCUMAB (REPATHA) for High cholesterol, PREGABALIN (LYRICA) for Neuropathy and Fibromyalgia, COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for Vitamin D deficiency.   On 13-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (Mild headache) and MYALGIA (body ache). The patient was treated with MENTHOL (SOMBRA COOL THERAPY) ongoing since an unknown date for Back pain, Movements reduced, Myalgia, Dizziness and Bedridden, at an unspecified dose and frequency. At the time of the report, HEADACHE (Mild headache) and MYALGIA (body ache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Everyone around her had COVID but tested 3 times but tested negative..     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient had not taken other vaccines within 1 month prior to Moderna COVID-19 vaccine. It was reported that the patient had booster dose date administered on Sunday. Concomitant medication information included took Vitamin D Rx (a medical prescription).  The patient was reporting a side effect that was pretty bad. The patient had body aches that were kicked in. Aches and pains were really bad, more so than they should have been. The patient had stayed in bed all day and slept but was able to get out of bed. The patient reported that still had pain in lower back and felt like it was on fire and however, the first day after the shot was really, really bad. The patient had not spoken to doctor yet. The adverse events had not caused the patient to seek medical care and the patient had a plan on calling doctor office when they open. Treatment medication information included Sombra - natural product topically apply to muscles.   This case was linked to MOD-2022-533526, MOD-2022-533530 (Patient Link).